BridgeBio Pharma (BBIO) Free Cash Flow (Quarterly): -44.46M

BridgeBio Pharma, Inc. (BBIO)

78.17 -1.37 (-1.72%) USD | NASDAQ | Nov 12, 16:00

77.76 -0.41 (-0.52%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Start Trial.

Date	Value
September 30, 2026	-44.46M
June 30, 2026	-71.54M
March 31, 2026	-197.35M
December 31, 2025	-56.45M
September 30, 2025	-112.44M
June 30, 2025	-85.78M
March 31, 2025	-200.83M
December 31, 2024	-198.56M
September 30, 2024	-182.30M
June 30, 2024	72.26M
March 31, 2024	-221.03M
December 31, 2023	-125.25M
September 30, 2023	-145.66M
June 30, 2023	-113.78M
March 31, 2023	-144.33M
December 31, 2022	-92.92M
September 30, 2022	-135.92M
June 30, 2022	-34.36M

Date	Value
March 31, 2022	-162.61M
December 31, 2021	-136.43M
September 30, 2021	-163.02M
June 30, 2021	-94.00M
March 31, 2021	-152.73M
December 31, 2020	-98.41M
September 30, 2020	-132.23M
June 30, 2020	-88.20M
March 31, 2020	-88.40M
December 31, 2019	-77.95M
September 30, 2019	-47.88M
June 30, 2019	-70.39M
March 31, 2019	-62.50M
December 31, 2018	-47.16M
September 30, 2018	-38.93M
June 30, 2018	-35.61M
March 31, 2018	-33.13M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks